Results 171 to 180 of about 4,684 (264)
In-situ solvothermal synthesis of FeNiSe/rGO electrocatalyst with superior performance for water splitting. [PDF]
Navazani S, Torabi F.
europepmc +1 more source
Osteosarcoma is the most common primary bone tumor with limited treatment options and a terrible prognosis. This review provides a comprehensive summary of the recent development of osteoimmunomodulatory implants for post‐operative osteosarcoma treatment, of which the potential utility in evoking durable anti‐osteosarcoma immunity and accelerating bone
Yilong Dong +6 more
wiley +1 more source
Modelling and improving approach for carrying capacity in multi-modal super network by considering travel time. [PDF]
Huang X.
europepmc +1 more source
The loss of Ubiquitin Specific Peptidase 26 (USP26) in osteoblasts results in decreased bone formation, as well as multi‐organ fibrosis associated with insulin resistance (IR). Mechanistically, the absence of USP26 reduces glycolysis and lactate accumulation, leading to decreased histone H3 lysine 18 lactylation (H3K18LA) in the promoter region of KH ...
Jiyuan Tang +9 more
wiley +1 more source
Future perspectives in esophageal manometry. [PDF]
Popa SL +11 more
europepmc +1 more source
METTL5 Enables Immune Evasion of Liver Cancer via Chemokine mRNA Translation Regulation
METTL5 reshapes the tumor immune microenvironment through ribosome 18S rRNA m6A modification to regulate the translation of chemokine mRNA. Targeting METTL5‐mediated immunosuppression unleashes anti‐tumor immunity and improves the efficacy of anti‐PD‐1 therapy.
Shuang Li +19 more
wiley +1 more source
Soft, breathable, and recyclable MXene fabrics for wearable electrophysiological recordings.
Lee K, Linares Gutierrez O, Bai W.
europepmc +1 more source
Regulation of Microstructure and Absorption Properties of MXene Materials: Theoretical and Experimental. [PDF]
Wang Q, Su X, Jia Y, Liu Y, Shahzad F.
europepmc +1 more source
PBRM1 ranks as the second most commonly mutated gene in ccRCC. This study reveals that PBRM1 loss promotes an immunosuppressive microenvironment by elevating M2 TAMs via the KDM5C–IL‐6 axis. These M2 TAMs, along with CAFs, form a barrier that excludes CD8+ T cells. Targeting IL‐6 synergizes with anti‐PD1 therapy, offering a promising strategy for PBRM1‐
Wenjiao Xia +14 more
wiley +1 more source
Riding the Highs and Lows of the Conduction System Pacing Wave-Our Experience. [PDF]
Teo HK +9 more
europepmc +1 more source

